The leader in know how and know why in oncology
We leverage provider and payer relationships, oncology experience and proprietary analytics to deliver actionable insights that drive successful market access.
Featured Insights
Article
Easier Pathway Access, Greater Pathway Usage
Easier access to oncology pathway recommendations encourages oncologists’ usage and considerations of these recommendations. Our new 2024-2025 Oncology Clinical Pathways Impact Report reveals the variability in pathway integration and usage.
Read More
Article
Unlocking Oncology Pathway Impact: Beyond Lives Covered to Real Prescribing Influence
As Oncology pathway programs continue to become more prominent in the marketplace, manufacturers are being challenged to assess how influential a specific pathway is.
Daniel Buchenberger
Podcast
Community Oncology Practice Economics - Podcast Part 3 of 3
In the final part of this 3-part podcast series, HMP Executive Vice President Lee Blansett and special guest John Hennessy—health system, provider and oncology strategist—explore emerging models for success in oncology practice economics.
Lee Blansett
Article
Bispecific Antibodies: A Balancing Act of Promise and Complexity
Bispecific antibodies have emerged with great promise, but adoption has been slower than expected. This was a key topic discussed by a panel of 5 experts at the October 2024 Association for Value-Based Cancer Care (AVBCC) conference.
Chris Van Denburg
The HMP Market Access Insights team helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.
Our Team
Lee Blansett
Executive Vice President
Cindy Chen
Head of Data Analytics
Chris Van Denburg
Director
